Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 10—October 2013
CME ACTIVITY - Research

Cryptococcus gattii Infections in Multiple States Outside the US Pacific Northwest

Julie R. HarrisComments to Author , Shawn R. Lockhart, Gail Sondermeyer, Duc J. Vugia, Matthew B. Crist, Melissa Tobin D’Angelo, Brenda Sellers, Carlos Franco-Paredes, Monear Makvandi, Chad Smelser, John Greene, Danielle Stanek, Kimberly Signs, Randall J. Nett, Tom Chiller, and Benjamin J. Park
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.R. Harris, S.R. Lockhart, R.J. Nett, T. Chiller, B.J. Park); California Department of Public Health, Richmond, California, USA (G. Sondemeyer, D.J. Vugia); Georgia Department of Public Health, Atlanta (M.B. Crist, M.T. D’Angelo); Phoebe Putney Memorial Hospital, Albany, Georgia, USA (B. Sellers, C. Franco-Paredes); Hospital Infantil Federico Gomez, Mexico City, Mexico (C. Franco-Paredes); New Mexico Department of Health, Santa Fe, New Mexico, USA (M. Mkvandi, C. Smelser); Moffitt Cancer Center, Tampa, Florida, USA (J. Greene); Florida Department of Health, Tallahassee, Florida, USA (D. Stanek); Michigan Department of Community Health, Lansing, Michigan, USA (K. Signs); Montana Department of Public Health and Human Services, Helena, Montana, USA (R.J. Nett)

Main Article

Table 3

Genotype of Cryptococcus gattii infection and known travel history of infected patients from outside the US Pacific Northwest, 2009–2013

State Genotype Known travel history
Alabama VGI No travel for many years; decades before, lived in Hawaii, Australia, and Asia
California VGI Unknown
California VGI Past-year travel to St. Louis, Missouri
California VGI Unknown
California VGI Unknown
California VGI Past-year travel to Betheseda, Maryland
California VGIII Past-year travel to Mexico
California VGIII Unknown
California VGIII Unknown
California VGIII Unknown
California VGIII Unknown
California VGIII Past-year travel to Mexico
California VGIII Unknown
California VGIIb Unknown
Florida VGIIb No travel outside of Florida for 20 years (21)
Georgia VGI No past-year travel
Georgia VGI No past-year travel
Georgia VGI Unknown
Georgia VGIII No travel for at least 2 years
Georgia VGIII Past-year travel to North Dakota; travel 5 years before illness to Montana
Hawaii VGII (not a/b/c) Past-year travel to Grand Canyon, Arizona, and Las Vegas, Nevada
Michigan VGIII Past-year travel to Albuquerque, New Mexico, and Denver, Colorado
Montana VGI Florida travel 3 years before illness; incarcerated in Montana for 7 months before illness onset
New Mexico VGI Frequent travel to Mexico, including during year before illness
New Mexico VGIII Never outside of New Mexico; incarcerated in New Mexico for 2 months before illness (20)

Main Article

References
  1. Chen  S, Sorrell  T, Nimmo  G, Speed  B, Currie  B, Ellis  D, Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31:499–508 and. DOIPubMedGoogle Scholar
  2. Harris  JR, Lockhart  SR, Debess  E, Marsden-Haug  N, Goldoft  M, Wohrle  R, Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis. 2011;53:1188–95 and. DOIPubMedGoogle Scholar
  3. MacDougall  L, Fyfe  M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol. 2006;44:1851–2 and. DOIPubMedGoogle Scholar
  4. Georgi  A, Schneemann  M, Tintelnot  K, Calligaris-Maibach  RC, Meyer  S, Weber  R, Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection. 2009;37:370–3 and. DOIPubMedGoogle Scholar
  5. Galanis  E, Macdougall  L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007. [Erratum in: Emerg Infect Dis. 2011;7:1784. Erratum in: Emerg Infect Dis. 2010 16:750]. Emerg Infect Dis. 2010;16:251–7. DOIPubMedGoogle Scholar
  6. Lalloo  D, Fisher  D, Naraqi  S, Laurenson  I, Temu  P, Sinha  A, Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. Q J Med. 1994;87:343–9 .PubMedGoogle Scholar
  7. Mitchell  DH, Sorrell  TC, Allworth  AM, Heath  CH, McGregor  AR, Papanaoum  K, Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis. 1995;20:611–6 and. DOIPubMedGoogle Scholar
  8. Speed  B, Dunt  D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995;21:28–34 and. DOIPubMedGoogle Scholar
  9. Kwon-Chung  KJ, Bennett  JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984;120:123–30 .PubMedGoogle Scholar
  10. Kwon-Chung  KJ, Bennett  JE. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg [A]. 1984;257:213–8 .PubMedGoogle Scholar
  11. Sorrell  TC. Cryptococcus neoformans variety gattii. Med Mycol. 2001;39:155–68 .PubMedGoogle Scholar
  12. López-Martínez  R, Soto-Hernández  JL, Ostrosky-Zeichner  L, Castanón-Olivares  LR, Angeles-Morales  V, Sotelo  J. Cryptococcus neoformans var. gattii among patients with cryptococcal meningitis in Mexico. First observations. Mycopathologia. 1996;134:61–4 and. DOIPubMedGoogle Scholar
  13. Perfect  JR, Dismukes  WE, Dromer  F, Goldman  DL, Graybill  JR, Hamill  RJ, Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291–322 and. DOIPubMedGoogle Scholar
  14. Brandt  ME, Hutwagner  LC, Klug  LA, Baughman  WS, Rimland  D, Graviss  EA, Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. J Clin Microbiol. 1996;34:912–7 .PubMedGoogle Scholar
  15. Chaturvedi  S, Dyavaiah  M, Larsen  RA, Chaturvedi  V. Cryptococcus gattii in AIDS patients, southern California. Emerg Infect Dis. 2005;11:1686–92 and. DOIPubMedGoogle Scholar
  16. Byrnes  EJ III, Bildfell  RJ, Frank  SA, Mitchell  TG, Marr  KA, Heitman  J. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis. 2009;199:1081–6 and. DOIPubMedGoogle Scholar
  17. Klein  KR, Hall  L, Deml  SM, Rysavy  JM, Wohlfiel  SL, Wengenack  NL. Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing. J Clin Microbiol. 2009;47:3669–72 and. DOIPubMedGoogle Scholar
  18. Meyer  W, Aanensen  DM, Boekhout  T, Cogliati  M, Diaz  MR, Esposto  MC, Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol. 2009;47:561–70 and. DOIPubMedGoogle Scholar
  19. Sellers  B, Hall  P, Cine-Gowdie  S, Hays  AL, Patel  K, Lockhart  SR, Cryptococcus gattii: an emerging fungal pathogen in the southeastern United States. Am J Med Sci. 2012;343:510–1 and. DOIPubMedGoogle Scholar
  20. Walraven  CJ, Gerstein  W, Hardison  SE, Wormley  F, Lockhart  SR, Harris  JR, Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS ONE. 2011;6:e28625 and. DOIPubMedGoogle Scholar
  21. Kunadharaju  R, Choe  U, Harris  JR, Lockhart  SR, Greene  JN. Cryptococcus gattii, Florida, USA, 2011. Emerg Infect Dis. 2013;19:519–21 and. DOIPubMedGoogle Scholar
  22. Sorrell  T, Chen  SA, Phillips  P, Marr  K. Clinical perspectives on Cryptococcus neoformans and Cryptococcus gattii: implications for diagnosis and management. In: Heitman J, Kozel TR, Kwon-Chung J, Perfect J, Casadevall A, editors. Cryptococcus: from pathogen to model yeast. Washington (DC): ASM Press; 2011. p. 595–606.
  23. Chau  TT, Mai  NH, Phu  NH, Nghia  HD, Chuong  LV, Sinh  DX, A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam—high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease. BMC Infect Dis. 2010;10:199 and. DOIPubMedGoogle Scholar
  24. Liao  CH, Chi  CY, Wang  YJ, Tseng  SW, Chou  CH, Ho  CM, Different presentations and outcomes between HIV-infected and HIV-uninfected patients with cryptococcal meningitis. J Microbiol Immunol Infect. 2012;45:296–304 and. DOIPubMedGoogle Scholar
  25. Ecevit  IZ, Clancy  CJ, Schmalfuss  IM, Nguyen  MH. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis. 2006;42:1443–7 and. DOIPubMedGoogle Scholar
  26. Einsiedel  L, Gordon  DL, Dyer  JR. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. Clin Infect Dis. 2004;39:e78–82 and. DOIPubMedGoogle Scholar
  27. Lui  G, Lee  N, Ip  M, Choi  KW, Tso  YK, Lam  E, Cryptococcosis in apparently immunocompetent patients. QJM. 2006;99:143–51 and. DOIPubMedGoogle Scholar
  28. Lane  M, McBride  J, Archer  J. Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis. Neurology. 2004;63:713–4 and. DOIPubMedGoogle Scholar
  29. Seaton  RA, Verma  N, Naraqi  S, Wembri  JP, Warrell  DA. The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis. Trans R Soc Trop Med Hyg. 1997;91:50–2 and. DOIPubMedGoogle Scholar
  30. Day  JN, Hoang  TN, Duong  AV, Hong  CT, Diep  PT, Campbell  JI, Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1. J Clin Microbiol. 2011;49:658–64 and. DOIPubMedGoogle Scholar
  31. Varma  A, Swinne  D, Staib  F, Bennett  JE, Kwon-Chung  KJ. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol. 1995;33:1807–14 .PubMedGoogle Scholar
  32. Johannson  KA, Huston  SM, Mody  CH, Davidson  W. Unique features of Cryptococcus gattii pneumonia—a prolonged incubation period in an immunocompetent host. Am J Respir Crit Care Med. 2011.
  33. Bennett  JE, Kwon-Chung  KJ, Howard  DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol. 1977;105:582–6 .PubMedGoogle Scholar
  34. Denton  JF, Di Salvo  AF. The prevalence of Cryptococcus neoformans in various natural habitats. Sabouraudia. 1968;6:213–7. DOIPubMedGoogle Scholar

Main Article

Page created: September 20, 2013
Page updated: September 20, 2013
Page reviewed: September 20, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external